Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

Study of Tecovirimat for Human Mpox Virus

ClinicalTrials.gov ID: NCT05534984

Public ClinicalTrials.gov record NCT05534984. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 2:30 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Placebo-Controlled, Double-Blinded Trial of the Safety and Efficacy of Tecovirimat for the Treatment of Human Mpox Virus Disease

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study was to see if tecovirimat is safe and successful at treating mpox. The main questions were whether tecovirimat reduced time to lesion resolution and pain compared to placebo (no treatment).

Study identification

NCT ID
NCT05534984
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Enrollment
719 participants

Conditions and interventions

Eligibility (public fields only)

Age range
Not listed
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 8, 2022 (Actual)
Primary completion
Oct 23, 2024 (Actual)
Completion
Feb 22, 2025 (Actual)
Last update posted
Jun 23, 2026

2022 – 2025

United States locations

U.S. sites
44
U.S. states
18
U.S. cities
33
Facility City State ZIP Site status
Alabama CRS Birmingham Alabama 35294 —
Kaiser Permanente Los Angeles Medical Center Los Angeles California 90027 —
Los Angeles LGBT Center CRS Los Angeles California 90028 —
UCLA CARE Center CRS Los Angeles California 90035 —
University of California, Davis CRS Sacramento California 95817 —
UCSD Antiviral Research Center CRS San Diego California 92103 —
University of California, San Francisco HIV/AIDS CRS San Francisco California 94110 —
Harbor University of California Los Angeles Center Torrance California 90502 —
University of Colorado Denver NICHD CRS Aurora Colorado 80045 —
University of Colorado Hospital CRS Aurora Colorado 80045 —
Denver Public Health CRS Denver Colorado 80204 —
University of Florida Gainesville Florida 32610 —
University of Florida Jacksonville NICHD CRS Jacksonville Florida 32209 —
University of Miami / Jackson Memorial Hospital Miami Florida 33136 —
Univ. of South Florida (USF) College of Medicine A Tampa Florida 33606 —
The Ponce de Leon Center CRS Atlanta Georgia 30308 —
Rush University Cook County Hospital Chicago NICHD CRS Chicago Illinois 60612 —
Johns Hopkins University CRS Baltimore Maryland 21205 —
Massachusetts General Hospital CRS (MGH CRS) Boston Massachusetts 02114 —
Brigham and Women's Hospital Therapeutics Boston Massachusetts 02115 —
Henry Ford Hospital CRS Detroit Michigan 48202 —
Washington University Therapeutics (WT) CRS St Louis Missouri 63110 —
New Jersey Medical School Clinical Research Center Newark New Jersey 07103 —
Weill Cornell Chelsea CRS New York New York 10010 —
Mount Sinai West Samuels CRS New York New York 10019 —
Harlem Prevention Center New York New York 10027 —
Columbia Physicians & Surgeons (P&S) CRS New York New York 10032 —
Weill Cornell Uptown CRS New York New York 10065 —
Bronx-Lebanon Hospital Center NICHD CRS New York New York 10457 —
Infectious Disease Clinical and Translational Research New York New York 11029 —
University of Rochester Adult HIV Therapeutic Rochester New York 14642 —
SUNY Stony Brook NICHD CRS Stony Brook New York 11794 —
Duke University Medical Center CRS Durham North Carolina 27710 —
Wake Forest Baptist Medical Center CRS Winston-Salem North Carolina 27157 —
Cincinnati CRS Cincinnati Ohio 45267 —
Case Western Reserve University CTU Cleveland Ohio 44106 —
Ohio State University CRS Columbus Ohio 43210 —
Penn Therapeutics CRS Philadelphia Pennsylvania 19104 —
University of Pittsburgh CRS Pittsburgh Pennsylvania 15213 —
St. Jude Children's Research Hospital ATN CRS Memphis Tennessee 38105 —
North Texas Infectious Disease Consultants Dallas Texas 75246 —
UT Southwestern Infectious Disease Research Unit Dallas Texas 75390 —
Houston AIDS Research Team (HART) CRS Houston Texas 77030 —
University of Washington Positive Research Seattle Washington 98104 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 10 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05534984, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 23, 2026 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05534984 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →